[HTML][HTML] Chronic cough: new insights and future prospects

A Morice, P Dicpinigaitis, L McGarvey… - European Respiratory …, 2021 - Eur Respiratory Soc
Chronic cough is defined in adults as a cough that lasts for≥ 8 weeks. When it proves
intractable to standard-of-care treatment, it can be referred to as refractory chronic cough …

Management of functional communication, swallowing, cough and related disorders: consensus recommendations for speech and language therapy

J Baker, C Barnett, L Cavalli, M Dietrich… - Journal of Neurology …, 2021 - jnnp.bmj.com
Communication problems (eg, dysphonia, dysfluency and language and articulation
disorders), swallowing disorders (dysphagia and globus), cough and upper airway …

Risk factors for chronic cough among 14,669 individuals from the general population

Y Çolak, BG Nordestgaard, LC Laursen, S Afzal… - Chest, 2017 - Elsevier
Background Risk factors for chronic cough in the general population have not been
described systematically. We identified and ranked chronic cough risk factors at the …

A randomized, double-blind, placebo-controlled, parallel-group phase 2b trial of P2X3 receptor antagonist sivopixant for refractory or unexplained chronic cough

L McGarvey, JA Smith, A Morice, SS Birring, KF Chung… - Lung, 2023 - Springer
Introduction To determine the optimal dose of sivopixant, a highly selective P2X3 receptor
antagonist, for refractory or unexplained chronic cough (RCC/UCC). Methods In this phase …

Chronic cough relief by allosteric modulation of P2X3 without taste disturbance

CR Guo, ZZ Zhang, X Zhou, MY Sun, TT Li… - Nature …, 2023 - nature.com
P2X receptors are cation channels that sense extracellular ATP. Many therapeutic
candidates targeting P2X receptors have begun clinical trials or acquired approval for the …

An update and systematic review on drug therapies for the treatment of refractory chronic cough

NM Ryan, AE Vertigan, SS Birring - Expert opinion on …, 2018 - Taylor & Francis
ABSTRACT Introduction: Chronic Cough (CC) is common and often associated with
significant comorbidity and decreased quality of life. In up to 50% of cases, the cough is …

Impaired cough suppression in chronic refractory cough

PSP Cho, HV Fletcher, RD Turner… - European …, 2019 - Eur Respiratory Soc
Functional brain imaging in individuals with chronic cough demonstrates reduced activation
in cortical regions associated with voluntary cough suppression. Little is known about the …

[HTML][HTML] Is laryngeal hypersensitivity the basis of unexplained or refractory chronic cough?

KM Sundar, AC Stark, N Hu… - ERJ Open …, 2021 - Eur Respiratory Soc
Refractory chronic cough (RCC) and unexplained chronic cough (UCC) are common
problems seen in primary care and subspecialty clinics. The role of cough hypersensitivity …

Efficacy and safety of pharmacotherapy for refractory or unexplained chronic cough: a systematic review and network meta-analysis

Z Zheng, J Huang, Z Xiang, T Wu, X Lan, S Xie… - …, 2023 - thelancet.com
Background Refractory chronic cough (RCC) has a significant impact on patient's health-
related quality of life and represents a challenge in clinical management. However, the …

Heterogeneity of cough hypersensitivity mediated by TRPV1 and TRPA1 in patients with chronic refractory cough

L Long, H Yao, J Tian, W Luo, X Yu, F Yi, Q Chen… - Respiratory …, 2019 - Springer
Background The differential sensitivity of cough to antitussive therapies implies the
existence of heterogeneity in cough hypersensitivity, but how such heterogeneity is …